← Back to Clinical Trials
Recruiting NCT07120074

NCT07120074 Dual-Task Exercise Effects on Balance and Cognition by Physical Performance Level

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07120074
Status Recruiting
Phase
Sponsor Bahçeşehir University
Condition Dual Task
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2025-08-03
Primary Completion 2025-10-04

Eligibility & Interventions

Sex All sexes
Min Age 20 Months
Max Age 50 Months
Study Type INTERVENTIONAL
Interventions
Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 52 participants in total. It began in 2025-08-03 with a primary completion date of 2025-10-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of dual-task exercises on balance and cognitive function in individuals with varying levels of physical performance. Dual-task training, which involves performing cognitive and motor activities simultaneously, has been shown to improve functional mobility, especially in older adults and patients with neurological conditions. However, limited data exist on how these effects differ among individuals with different physical capacities. The findings of this study will contribute to understanding the therapeutic value of dual-task exercises in promoting both physical and cognitive health.

Eligibility Criteria

Inclusion Criteria: Aged between 20 and 50 years Adequate cognitive function to understand instructions and participate in the study Willingness and ability to participate regularly in the exercise program Ability to comprehend and follow the study procedures Exclusion Criteria: Diagnosed with rheumatoid arthritis Diagnosed with systemic lupus erythematosus (SLE) Diagnosed with Parkinson's disease Diagnosed with multiple sclerosis History of stroke Diagnosed with Alzheimer's disease or other dementias Diagnosed with scoliosis causing physical limitation History of lower limb fractures Presence of foot or ankle tendonitis Diagnosed with color blindness or legal blindness History of major surgery (e.g., orthopedic, spinal, abdominal) within the past 6 months Irregular attendance or non-compliance with the exercise protocol

Contact & Investigator

Central Contact

TÜLİN ÜNAL

✉ tulin409@hotmail.com

📞 +90 5063689951

Principal Investigator

tulin unal

PRINCIPAL INVESTIGATOR

bağlantısız

Frequently Asked Questions

Who can join the NCT07120074 clinical trial?

This trial is open to participants of all sexes, aged 20 Months or older, up to 50 Months, studying Dual Task. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07120074 currently recruiting?

Yes, NCT07120074 is actively recruiting participants. Contact the research team at tulin409@hotmail.com for enrollment information.

Where is the NCT07120074 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07120074 clinical trial?

NCT07120074 is sponsored by Bahçeşehir University. The principal investigator is tulin unal at bağlantısız. The trial plans to enroll 52 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology